Conference to be held in New York City September 9-11th Marlborough, Massachusetts–(Newsfile Corp. – September 9, 2024) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced that its President and CEO, Robert […]